Published in Curr Microbiol on March 16, 2010
Histone deacetylase inhibitors as a tool to up-regulate new fungal biosynthetic products: isolation of EGM-556, a cyclodepsipeptide, from Microascus sp. Org Lett (2010) 0.85
Two genomes are better than one: history, genetics, and biotechnological applications of fungal heterokaryons. Fungal Biol Biotechnol (2016) 0.75
LaeA, a regulator of secondary metabolism in Aspergillus spp. Eukaryot Cell (2004) 3.72
Genome shuffling of Lactobacillus for improved acid tolerance. Nat Biotechnol (2002) 2.46
LaeA, a regulator of morphogenetic fungal virulence factors. Eukaryot Cell (2005) 2.21
Biology and chemistry of endophytes. Nat Prod Rep (2006) 2.08
Genome shuffling leads to rapid phenotypic improvement in bacteria. Nature (2002) 2.04
Improvement of microbial strains and fermentation processes. Appl Microbiol Biotechnol (2000) 1.77
Activation of fungal silent gene clusters: a new avenue to drug discovery. Prog Drug Res (2008) 1.36
The global regulator LaeA controls penicillin biosynthesis, pigmentation and sporulation, but not roquefortine C synthesis in Penicillium chrysogenum. Biochimie (2008) 1.27
Accurate prediction of the Aspergillus nidulans terrequinone gene cluster boundaries using the transcriptional regulator LaeA. Fungal Genet Biol (2007) 1.23
Taxol from Tubercularia sp. strain TF5, an endophytic fungus of Taxus mairei. FEMS Microbiol Lett (2000) 1.11
Engineering complex phenotypes in industrial strains. Biotechnol Prog (2007) 1.06
Genome shuffling improves degradation of the anthropogenic pesticide pentachlorophenol by Sphingobium chlorophenolicum ATCC 39723. Appl Environ Microbiol (2004) 1.05
Screening of species of the endophytic fungus Phomopsis for the production of the anticancer drug taxol. Biotechnol Appl Biochem (2009) 1.03
Paclitaxel-induced microtubule stabilization causes mitotic block and apoptotic-like cell death in a paclitaxel-sensitive strain of Saccharomyces cerevisiae. Yeast (2005) 0.93
Charting gene regulatory networks: strategies, challenges and perspectives. Biochem J (2004) 0.90
New biosynthetic step in the melanin pathway of Wangiella (Exophiala) dermatitidis: evidence for 2-acetyl-1,3,6,8-Tetrahydroxynaphthalene as a novel precursor. Eukaryot Cell (2008) 0.87
A global view of metabolites. Chem Biol (2006) 0.82
Silencing of the aflatoxin gene cluster in a diploid strain of Aspergillus flavus is suppressed by ectopic aflR expression. Genetics (2007) 0.81
Identification of 1,8-dihydroxynaphthalene melanin in Monosporascus cannonballus and the analysis of hexaketide and pentaketide compounds produced by wild-type and pigmented isolates of the fungus. J Agric Food Chem (2004) 0.78
Further studies on protoplast fusion and interspecific hybridization within the Aspergillus nidulans group. J Gen Microbiol (1984) 0.76
Production of Trichoderma strains with pesticide-polyresistance by mutagenesis and protoplast fusion. Antonie Van Leeuwenhoek (2006) 0.75
Secondary metabolites of Tubercularia sp. TF5, an endophytic fungal strain of Taxus mairei. Nat Prod Res (2009) 0.75
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med (2006) 6.18
Sustained small interfering RNA delivery by mesoporous silicon particles. Cancer Res (2010) 2.80
MYC suppresses cancer metastasis by direct transcriptional silencing of αv and β3 integrin subunits. Nat Cell Biol (2012) 2.61
Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma. Cancer Res (2007) 1.90
Efficacy and antivascular effects of EphA2 reduction with an agonistic antibody in ovarian cancer. J Natl Cancer Inst (2006) 1.87
A microRNA regulatory mechanism of osteoblast differentiation. Proc Natl Acad Sci U S A (2009) 1.80
Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer. J Natl Cancer Inst (2013) 1.78
Laminin and biomimetic extracellular elasticity enhance functional differentiation in mammary epithelia. EMBO J (2008) 1.74
Surgical stress promotes tumor growth in ovarian carcinoma. Clin Cancer Res (2009) 1.73
Metronomic chemotherapy enhances the efficacy of antivascular therapy in ovarian cancer. Cancer Res (2007) 1.66
Cell shape regulates global histone acetylation in human mammary epithelial cells. Exp Cell Res (2007) 1.64
Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis. J Biol Chem (2010) 1.58
Cytosporone B is an agonist for nuclear orphan receptor Nur77. Nat Chem Biol (2008) 1.58
Sema3A regulates bone-mass accrual through sensory innervations. Nature (2013) 1.53
Clinical and biological significance of vascular endothelial growth factor in endometrial cancer. Clin Cancer Res (2007) 1.51
Combined anti-angiogenic therapy against VEGF and integrin alphaVbeta3 in an orthotopic model of ovarian cancer. Cancer Biol Ther (2009) 1.47
Biosynthesis of HSAF, a tetramic acid-containing macrolactam from Lysobacter enzymogenes. J Am Chem Soc (2010) 1.46
Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy. Clin Cancer Res (2007) 1.45
Bioactive natural products from Lysobacter. Nat Prod Rep (2012) 1.42
Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles. Neoplasia (2011) 1.42
Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population. Blood (2008) 1.39
Intraperitoneal delivery of liposomal siRNA for therapy of advanced ovarian cancer. Cancer Biol Ther (2006) 1.38
EphA2 immunoconjugate as molecularly targeted chemotherapy for ovarian carcinoma. J Natl Cancer Inst (2009) 1.37
Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth. Oncogene (2002) 1.34
Targeted gene silencing using RGD-labeled chitosan nanoparticles. Clin Cancer Res (2010) 1.34
Dual targeting of EphA2 and FAK in ovarian carcinoma. Cancer Biol Ther (2009) 1.30
Identification and characterization of the anti-methicillin-resistant Staphylococcus aureus WAP-8294A2 biosynthetic gene cluster from Lysobacter enzymogenes OH11. Antimicrob Agents Chemother (2011) 1.27
Depletion of nuclear actin is a key mediator of quiescence in epithelial cells. J Cell Sci (2011) 1.16
The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin. Breast Cancer Res Treat (2011) 1.14
Retracted Secondary metabolites from endophytic Streptomyces aureofaciens CMUAc130 and their antifungal activity. Microbiology (2005) 1.13
AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity. Oncogene (2004) 1.12
Extracellular matrix, nuclear and chromatin structure, and gene expression in normal tissues and malignant tumors: a work in progress. Adv Cancer Res (2007) 1.11
Antitumor and antivascular effects of AVE8062 in ovarian carcinoma. Cancer Res (2007) 1.11
A closed-loop brain-computer interface triggering an active ankle-foot orthosis for inducing cortical neural plasticity. IEEE Trans Biomed Eng (2014) 1.11
Enhanced low-latency detection of motor intention from EEG for closed-loop brain-computer interface applications. IEEE Trans Biomed Eng (2014) 1.08
Clinical value of serum HMGB1 levels in early detection of recurrent squamous cell carcinoma of uterine cervix: comparison with serum SCCA, CYFRA21-1, and CEA levels. Croat Med J (2009) 1.08
Conatumumab, a fully human agonist antibody to death receptor 5, induces apoptosis via caspase activation in multiple tumor types. Cancer Biol Ther (2010) 1.06
FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice. J Clin Invest (2012) 1.06
Localization of plasma membrane and secretory calcium pumps in the mammary gland. Biochem Biophys Res Commun (2008) 1.06
Biological roles of the Delta family Notch ligand Dll4 in tumor and endothelial cells in ovarian cancer. Cancer Res (2011) 1.05
RORα suppresses breast tumor invasion by inducing SEMA3F expression. Cancer Res (2012) 1.04
Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer. Cancer Biol Ther (2010) 1.04
Bridging the gap between cytotoxic and biologic therapy with metronomic topotecan and pazopanib in ovarian cancer. Mol Cancer Ther (2010) 1.04
Targeting aurora kinase with MK-0457 inhibits ovarian cancer growth. Clin Cancer Res (2008) 1.04
Circulating cell-free DNA: a novel biomarker for response to therapy in ovarian carcinoma. Cancer Biol Ther (2006) 1.03
Adipose-derived mesenchymal stem cells protect PC12 cells from glutamate excitotoxicity-induced apoptosis by upregulation of XIAP through PI3-K/Akt activation. Toxicology (2010) 1.03
Knockdown of Dicer in MCF-7 human breast carcinoma cells results in G1 arrest and increased sensitivity to cisplatin. Oncol Rep (2009) 1.02
Cidea is an essential transcriptional coactivator regulating mammary gland secretion of milk lipids. Nat Med (2012) 1.00
Spiroindimicins A-D: new bisindole alkaloids from a deep-sea-derived actinomycete. Org Lett (2012) 1.00
Dopamine blocks stress-mediated ovarian carcinoma growth. Clin Cancer Res (2011) 1.00
Gene expression in the third dimension: the ECM-nucleus connection. J Mammary Gland Biol Neoplasia (2010) 0.99
The AP-1 transcription factor regulates postnatal mammary gland development. Dev Biol (2006) 0.99
Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2. Cell Cycle (2008) 0.98
Biosynthetic mechanism for sunscreens of the biocontrol agent Lysobacter enzymogenes. PLoS One (2013) 0.95
Sugar and auxin signaling pathways respond to high-temperature stress during anther development as revealed by transcript profiling analysis in cotton. Plant Physiol (2014) 0.94
Targeting SRC in mucinous ovarian carcinoma. Clin Cancer Res (2011) 0.93
The Axin/TNKS complex interacts with KIF3A and is required for insulin-stimulated GLUT4 translocation. Cell Res (2012) 0.91
Seco-pregnane steroids target the subgenomic RNA of alphavirus-like RNA viruses. Proc Natl Acad Sci U S A (2007) 0.91
Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology. ACS Nano (2015) 0.91
NFkB disrupts tissue polarity in 3D by preventing integration of microenvironmental signals. Oncotarget (2013) 0.90
3-Acetonyl-3-hydroxyoxindole: a new inducer of systemic acquired resistance in plants. Plant Biotechnol J (2008) 0.90
Two new antifungal saponins from the Tibetan herbal medicine Clematis tangutica. Planta Med (2003) 0.90
Unusual activities of the thioesterase domain for the biosynthesis of the polycyclic tetramate macrolactam HSAF in Lysobacter enzymogenes C3. Biochemistry (2011) 0.90
ATP11B mediates platinum resistance in ovarian cancer. J Clin Invest (2013) 0.88
Cytosporone B, an inhibitor of the type III secretion system of Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother (2013) 0.88
Identification and characterization of the cuevaene A biosynthetic gene cluster in streptomyces sp. LZ35. Chembiochem (2013) 0.88
A new route toward light emission from Ge: tensile-strained quantum dots. Nanoscale (2015) 0.88
Oridonin phosphate-induced autophagy effectively enhances cell apoptosis of human breast cancer cells. Med Oncol (2014) 0.87
Krüppel-like factor 4 regulates intestinal epithelial cell morphology and polarity. PLoS One (2012) 0.87
Chemical constituents and diversity of Ligularia lankongensis in Yunnan Province of China. J Nat Prod (2008) 0.87
Corilagin inhibits hepatocellular carcinoma cell proliferation by inducing G2/M phase arrest. Cell Biol Int (2013) 0.86
Photonic gene circuits by optically addressable siRNA-Au nanoantennas. ACS Nano (2012) 0.86
Metronomic activity of CD44-targeted hyaluronic acid-paclitaxel in ovarian carcinoma. Clin Cancer Res (2012) 0.85
Identification of a small molecule signaling factor that regulates the biosynthesis of the antifungal polycyclic tetramate macrolactam HSAF in Lysobacter enzymogenes. Appl Microbiol Biotechnol (2014) 0.85
Biological significance of HORMA domain containing protein 1 (HORMAD1) in epithelial ovarian carcinoma. Cancer Lett (2012) 0.85
Structural and optical characterizations of InPBi thin films grown by molecular beam epitaxy. Nanoscale Res Lett (2014) 0.85
Biosynthesis of 3,5-AHBA-derived natural products. Nat Prod Rep (2011) 0.84
Selective isolation and ansamycin-targeted screenings of commensal actinomycetes from the "maytansinoids-producing" arboreal Trewia nudiflora. Curr Microbiol (2008) 0.84
Facile method for site-specific gene integration in Lysobacter enzymogenes for yield improvement of the anti-MRSA antibiotics WAP-8294A and the antifungal antibiotic HSAF. ACS Synth Biol (2013) 0.83
Mycoepoxydiene inhibits lipopolysaccharide-induced inflammatory responses through the suppression of TRAF6 polyubiquitination [corrected]. PLoS One (2012) 0.83
Secondary metabolites of Aspergillus sp. F1, a commensal fungal strain of Trewia nudiflora. Nat Prod Res (2009) 0.83
Hygrocins C-G, cytotoxic naphthoquinone ansamycins from gdmAI-disrupted Streptomyces sp. LZ35. J Nat Prod (2013) 0.83
Targeting SRC and tubulin in mucinous ovarian carcinoma. Clin Cancer Res (2013) 0.83
QSG-7701 human hepatocytes form polarized acini in three-dimensional culture. J Cell Biochem (2010) 0.83
FRS2α is essential for the fibroblast growth factor to regulate the mTOR pathway and autophagy in mouse embryonic fibroblasts. Int J Biol Sci (2011) 0.82
RORα, a potential tumor suppressor and therapeutic target of breast cancer. Int J Mol Sci (2012) 0.82
Amide N-glycosylation by Asm25, an N-glycosyltransferase of ansamitocins. Chem Biol (2008) 0.82
Biologic effects of dopamine on tumor vasculature in ovarian carcinoma. Neoplasia (2013) 0.82
Cross-talk between EphA2 and BRaf/CRaf is a key determinant of response to Dasatinib. Clin Cancer Res (2014) 0.82